The Procter & Gamble Company (NYSE:PG) Shares Acquired by Coston McIsaac & Partners

Coston McIsaac & Partners raised its holdings in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 0.8% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 44,020 shares of the company’s stock after acquiring an additional 355 shares during the quarter. Procter & Gamble makes up 2.2% of Coston McIsaac & Partners’ investment portfolio, making the stock its 10th biggest holding. Coston McIsaac & Partners’ holdings in Procter & Gamble were worth $7,623,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Wulff Hansen & CO. grew its holdings in Procter & Gamble by 16,292.0% during the 2nd quarter. Wulff Hansen & CO. now owns 3,675,902 shares of the company’s stock valued at $606,230,000 after buying an additional 3,653,477 shares during the last quarter. TD Asset Management Inc grew its holdings in shares of Procter & Gamble by 114.9% during the first quarter. TD Asset Management Inc now owns 3,568,671 shares of the company’s stock valued at $579,017,000 after purchasing an additional 1,907,716 shares during the last quarter. AMF Tjanstepension AB grew its holdings in Procter & Gamble by 416.1% in the 3rd quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock worth $315,016,000 after buying an additional 1,466,115 shares in the last quarter. Swedbank AB bought a new position in Procter & Gamble in the 1st quarter worth approximately $233,788,000. Finally, Ilex Capital Partners UK LLP acquired a new stake in Procter & Gamble in the first quarter worth approximately $228,212,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 96,000 shares of the firm’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $170.00, for a total value of $16,320,000.00. Following the transaction, the chief executive officer now directly owns 13,721 shares of the company’s stock, valued at approximately $2,332,570. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, CEO Ma. Fatima Francisco sold 96,000 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $170.00, for a total transaction of $16,320,000.00. Following the transaction, the chief executive officer now directly owns 13,721 shares of the company’s stock, valued at $2,332,570. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Susan Street Whaley sold 450 shares of the firm’s stock in a transaction dated Tuesday, August 20th. The shares were sold at an average price of $169.22, for a total transaction of $76,149.00. Following the transaction, the insider now directly owns 13,072 shares in the company, valued at $2,212,043.84. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 383,194 shares of company stock worth $65,140,718 over the last three months. 0.18% of the stock is owned by company insiders.

Procter & Gamble Price Performance

Shares of Procter & Gamble stock traded down $0.76 on Wednesday, reaching $168.94. 952,471 shares of the stock were exchanged, compared to its average volume of 6,663,125. The firm’s 50 day moving average is $171.87 and its 200-day moving average is $167.43. The Procter & Gamble Company has a one year low of $142.50 and a one year high of $177.94. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.53 and a current ratio of 0.73. The firm has a market cap of $398.72 billion, a PE ratio of 29.21, a P/E/G ratio of 3.72 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The business had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same quarter in the prior year, the firm earned $1.83 EPS. The firm’s revenue was down .6% compared to the same quarter last year. As a group, analysts anticipate that The Procter & Gamble Company will post 6.98 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.38%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.

Analysts Set New Price Targets

A number of analysts have recently issued reports on PG shares. TD Cowen assumed coverage on Procter & Gamble in a report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 target price for the company. Wolfe Research upgraded shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Morgan Stanley upped their price target on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a report on Monday. Dbs Bank cut shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 1st. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $164.00 target price on shares of Procter & Gamble in a research note on Monday. Nine equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $177.00.

Read Our Latest Report on PG

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Featured Stories

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.